EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria

Maya M Leibowitz, Ryan Cooper, Stefania Kaninia, Kathryn I Challis, Will Greenway, Maria Bonello, Mahmoud Elbahnasawi, Deborah T Shode, Dominika Gajdasik, Victor Iliev, Alison M E Whitelegg, Ian Galea iD

Annals of Clinical and Translational Neurology · 2026

DOI: 10.1002/acn3.70300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2026. Verfasst von Maya M Leibowitz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Immunoglobulin kappa-Chains, Multiple Sclerosis, Oligoclonal Bands. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, The Binding Site (Part of Thermo Fisher Scientific).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2) equivalence to OCB in the specific clinical scenario when demonstration of intrathecal immunoglobulin synthesis is essential for MS diagnosis; (3) which KFLC metric has the best diagnostic performance.

Methods

A retrospective study of 740 cases was conducted, categorised into three groups: MS (2024 McDonald criteria), other neuroinflammatory disorders and non‐inflammatory groups. CSF and serum KFLC and albumin were assayed with immunoturbidimetry. OCB status was assessed using isoelectric focusing. Eight KFLC metrics were tested: CSF KFLC, KFLC index, three population‐based models of the upper limit for the CSF/serum kappa quotient corrected for CSF/serum albumin quotient, and their corresponding intrathecal fractions.

Results

The KFLC index and the KFLC intrathecal fraction performed as well as OCB; no cases were missed when KFLC was mandatory to achieve a MS diagnosis. Intrathecal fraction computation improved the performance of the population‐based models.

Interpretation

In the setting of the 2024 McDonald criteria, KFLC metrics correcting for the CSF/serum albumin quotient were equivalent to OCBs. The intrathecal fraction provided no advantage over the KFLC index, which is simpler to compute. Importantly, the KFLC index can replace OCB when CSF positivity is essential for diagnosis. We provide an explanation for KFLC's comparable diagnostic performance despite its inability to identify CSF‐only clones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin kappa-ChainsMultiple SclerosisOligoclonal BandsHumansRetrospective StudiesFemaleMaleAdultMiddle Aged

Stichwörter der Autor:innen

kappa light chainsmultiple sclerosisoligoclonal bands

Substanzen

Immunoglobulin kappa-ChainsOligoclonal Bands

Autor:innen und Institutionen

  • Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Clinical Biochemistry, University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK.
  • Clinical Immunology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • The Binding Site (Part of Thermo Fisher Scientific), Birmingham, UK.

ORCID-Profile: Ian Galea

Förderung

  • National Institute for Health and Care Research
  • The Binding Site (Part of Thermo Fisher Scientific)

Zitieren

APA

Leibowitz, M. M., Cooper, R., Kaninia, S., Challis, K. I., Greenway, W., Bonello, M., Elbahnasawi, M., Shode, D. T., Gajdasik, D., Iliev, V., Whitelegg, A. M. E., & Galea, I. (2026). Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70300

Vancouver

Leibowitz MM, Cooper R, Kaninia S, Challis KI, Greenway W, Bonello M, et al. Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70300

BibTeX
@article{Leibowitz2026,
  author = {Leibowitz, Maya M and Cooper, Ryan and Kaninia, Stefania and Challis, Kathryn I and Greenway, Will and Bonello, Maria and Elbahnasawi, Mahmoud and Shode, Deborah T and Gajdasik, Dominika and Iliev, Victor and Whitelegg, Alison M E and Galea, Ian},
  title = {Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  doi = {10.1002/acn3.70300}
}
Kostenlos starten →